Canaccord lowered the firm’s price target on Edgewell Personal Care (EPC) to $32 from $35 and keeps a Buy rating on the shares. The firm said they reported a Q3 miss but as they head into Q4 management expects organic sales to return to growth due to strength in their “Right to Win” portfolio and expectations to grow international.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EPC:
- Edgewell Personal Care: Hold Rating Amidst Valuation Challenges and Future Growth Pressures
- Edgewell upgraded to Equal Weight from Underweight at Morgan Stanley
- Edgewell Personal Care Reports Q3 2025 Earnings
- Edgewell Personal Care Co Faces Challenges Amid Growth
- Edgewell Personal Care reports Q3 adjusted EPS 92c, consensus 99c